Verhoest, Patrick R.
Pfizer (United States)
2 papers on CoChat
Most cited papers
- Verified
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 2,033
- Verified
Central nervous system multiparameter optimization desirability: Application in drug discovery
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2016) · ACS Chemical Neuroscience
Computational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases
Cited by 653
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free